Amy Cayne Schwartz, J.D., is the President and General Counsel of Genome Project-write (GP-write) and Co-Founder of Base Pair-Go. Since 2016, Amy has assumed various roles on GP-write ranging from legal to entrepreneurial such as the initial buildout of the 501(c)(3) and corporate governance structure as well as the establishment and operation of nine working groups ranging from technology to ethics and education. Currently, Amy is focused on launching the first virtual foundry and incubator for genome-scale writing and redesign. Concurrent with this effort is the development of a first-of-its kind CAD platform to enable whole-scale genome design and the establishment of an Industry Advisory Board with leaders in the field of bioengineering, genomics and synthetic biology to help shape and influence these pioneering initiatives.

Amy is a Venture Partner at Cymba X, a venture fund focused on investing in DNA and RNA science and technologies. In addition, Amy is currently leading Business Development for an early-stage biotech venture as well as serving the company’s General Counsel.

Prior to joining GP-write, Amy was an Associate at the law firm Nixon Peabody LLP, practicing in the areas of complex litigation and real estate law. She also worked as an Associate at the law firm Cadwalader, Wickersham & Taft LLP as a member of the Real Estate Finance and Securitization teams.

Amy holds a B.A. in Political Science from the University of Pennsylvania, and studied at The London School of Economics (LSE). She holds a J.D. from Fordham University School of Law, where she was a member of the Intellectual Property, Media and Entertainment Law Journal, and has a Certification in Biomanufacturing from the Massachusetts Institute of Technology (M.I.T.).